Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun;87(6):510-520.
doi: 10.1037/ccp0000409. Epub 2019 Apr 22.

Estimating outcome probabilities from early symptom changes in cognitive therapy for recurrent depression

Affiliations

Estimating outcome probabilities from early symptom changes in cognitive therapy for recurrent depression

Jeffrey R Vittengl et al. J Consult Clin Psychol. 2019 Jun.

Abstract

Objective: Acute-phase cognitive therapy (CT) is an efficacious treatment for major depressive disorder (MDD) producing benefits comparable to pharmacotherapy, but not all patients respond or remit. The purpose of the current analyses was to estimate CT patients' probability of nonresponse and remission from symptom improvement early in treatment.

Method: Data from 2 clinical trials of acute-phase CT for recurrent depression were pooled for analysis (N = 679). Adult outpatients received 16- or 20-session CT protocols. Symptoms were measured repeatedly with the clinician-report Hamilton Rating Scale for Depression (HRSD) and Inventory of Depressive Symptomatology-Self-Report (IDS-SR). Outcomes at exit from CT were nonresponse (<50% reduction in HRSD scores) and remission (no MDD and HRSD score ≤6).

Results: The nonresponse rate was 45.7%, and the remission rate was 33.4%. In logistic regression models, improvements on the HRSD or IDS-SR from intake to CT Sessions 3, 5, 7, 9, or 11 significantly predicted both outcomes, with prediction gaining in accuracy in later sessions. Clinician and self-report assessments yielded similar results. Prediction of outcomes replicated across data sets. Patients with no symptom improvement by CT Session 9 (Week 5) had ≤10% probability of remission and >75% probability of nonresponse.

Conclusions: Outcomes of CT for depression are predictable from early symptom changes. Clinicians may find nonresponse and remission probability estimates useful in the informed consent process and in choosing whether to continue, augment, or switch treatments for CT patients with recurrent MDD. (PsycINFO Database Record (c) 2019 APA, all rights reserved).

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Predicted probability of outcomes to acute-phase cognitive therapy as a function of symptom change on the Hamilton Rating Scale for Depression from intake to session 9. Black lines (probabilities decreasing from left to right) refer to non-response (< 50% reduction in HRSD score), whereas gray lines (probabilities increasing from left to right) refer to remission (no major depressive disorder and final HRSD score ≤ 6) at exit from cognitive therapy. Dashed lines mark 95% confidence intervals. Additional lines connect .50 probabilities of outcomes (on the vertical axis) with symptom decreases (on the horizontal axis).
Figure 2.
Figure 2.
Predicted probability of outcomes to acute-phase cognitive therapy as a function of symptom change on the Inventory of Depressive Symptomatology—Self-report from intake to session 9. Black lines (probabilities decreasing from left to right) refer to non-response (< 50% reduction in HRSD score), whereas gray lines (probabilities increasing from left to right) refer to remission (no major depressive disorder and final HRSD score ≤ 6) at exit from cognitive therapy. Dashed lines mark 95% confidence intervals. Additional lines connect .50 probabilities of outcomes (on the vertical axis) with symptom decreases (on the horizontal axis).

Similar articles

Cited by

  • Clinical research challenges posed by difficult-to-treat depression.
    Rush AJ, Sackeim HA, Conway CR, Bunker MT, Hollon SD, Demyttenaere K, Young AH, Aaronson ST, Dibué M, Thase ME, McAllister-Williams RH. Rush AJ, et al. Psychol Med. 2022 Feb;52(3):419-432. doi: 10.1017/S0033291721004943. Epub 2022 Jan 7. Psychol Med. 2022. PMID: 34991768 Free PMC article. Review.

References

    1. Aderka IM, Nickerson A, Bøe HJ, & Hofmann SG (2012). Sudden gains during psychological treatments of anxiety and depression: A meta-analysis. Journal of Consulting and Clinical Psychology, 80, 93–101. - PubMed
    1. American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders (4th ed.). Washington, DC: Author.
    1. American Psychiatric Association. (2000). Diagnostic and Statistical Manual of Mental Disorders (4th ed., text rev.). Washington, DC: Author.
    1. Barkham M, Connell J, Stiles WB, Miles JNV, Margison F, Evans C, & Mellor-Clark J. (2006). Dose-effect relations and responsive regulation of treatment duration: the good enough level. Journal of Consulting and Clinical Psychology, 74, 160–167. - PubMed
    1. Beck AT, & Haigh EP (2014). Advances in cognitive theory and therapy: The generic cognitive model. Annual Review of Clinical Psychology, 10, 1–24. - PubMed